Life Sciences

The research in the Life Sciences category spans a wide range of sectors related to, and driven by, the biological sciences. This range runs from basic laboratory research tools and services through applications in medicine, agriculture, and even some aspects of environmental and materials sectors. Our market research reports cover the Biotechnology, Pharmaceuticals, Diagnostics, Healthcare, and Medical Devices industries, offering in-depth analysis of markets, trends, and competitors.

By far the biggest industries in the life sciences category are related to human healthcare, including pharmaceuticals; diagnostics; medical devices; and healthcare facilities, delivery, policy and financing. Although heavily regulated in most parts of the globe, human healthcare continues to be a high-growth and often high-margin sector driven by technological innovation, ever-increasing demand, and well-developed funding and public sector support. It is not unusual for breakthrough products in this sector to experience explosive double- and triple-digit growth in their early years, and even products and services that are mere commodities in other markets can find premium value when associated with clinical applications. Despite this luring promise, the complex regulatory, technological, and financial dynamics of this sector make it one of the most challenging to manufacturers and marketers.
Page 4/28
Category Tools

Sonic Healthcare Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Fresenius Kabi AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sanofi Pasteur SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Regulus Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Applied Biosystems, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

ICON Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Jubilant Life Sciences Limited (formerly known as Jubilant Organosys, Ltd.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

United Therapeutics Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

F. Hoffmann-La Roche, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Nuvo Research, Inc. (formerly Dimethaid Research, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Hadasit Medical Research Services & Development, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Marina Biotech, Inc. (Formerly MDRNA, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Astellas Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sun Pharmaceutical Industries Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Medivir AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Barr Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

MEDNAX, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Kindred Healthcare, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Labopharm, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Hologic, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cancer Research Technology Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Immunomedics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Eurand N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

EUSA Pharma, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

BTG plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Rosetta Genomics, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Eurofins Scientific S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Cardium Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

GenVec, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Profectus BioSciences, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

454 Life Sciences - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Depomed, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Syneron Medical, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

MedImmune, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

CryoLife, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sequenom, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Boston Scientific Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Dr. Reddy's Laboratories, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Merrimack Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Eisai, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Sarepta Therapeutics, Inc. (Formerly AVI BioPharma, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

QRxPharma Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Boehringer Ingelheim GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Asuragen, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Ipsogen SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Wright Medical Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Alexion Pharmaceuticals, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00

Charles River Laboratories International, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

July 2013 · MarketLine Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. € 259,00
Options